Literature DB >> 1739916

Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes.

F Pandolfi1, L Trentin, L A Boyle, I Stamenkovic, H R Byers, R B Colvin, J T Kurnick.   

Abstract

The role of cell adhesion molecules (CAM) LFA1, ICAM-1, LFA3, VLA1, VLA4, CD29, CD44, and CD56 in tumor-infiltrating lymphocyte (TIL) and natural killer cell (NK)-mediated killing of target cells was studied. Melanoma cell lines and autologous TIL were derived from seven patients with metastatic melanoma, and cytotoxicity assays were done in the presence and absence of monoclonal antibodies (MoAb) to CAM expressed on melanoma cells or TIL. The melanoma cell lines analyzed were all positive for CD29 and LFA3 expression, negative for LFA1 expression, but showed variable expression of ICAM-1, VLA1, VLA4, CD44, and CD56. The effects of anti-CAM antibodies on TIL-mediated melanoma killing fell into three categories: (1) consistent inhibition of TIL-mediated killing was observed when melanoma cells were pretreated with anti-ICAM1 and anti-LFA-3 MoAb or when TIL were pretreated with anti-LFA1; (2) no effect was observed when melanoma cells were pretreated with anti-CD56; or (3) a discreet, but significant, inhibition was observed when target cells were pretreated with anti-CD29, anti-VLA1, anti-VLA4, and anti-CD44. Cytotoxicity was significantly enhanced by pretreatment of target cells with gamma-interferon (gamma-IFN), although gamma-IFN did not augment surface expression of the CAM studied. The NK-mediated killing of K562 cells was blocked by anti-LFA1, anti-CD18, and anti-ICAM, and partially inhibited by anti-CD44 MoAb. Together, these results suggest that several accessory CAM may play a role in regulating cellular cytotoxicity. Because cytotoxicity generally correlated with the level of expression of CAM in melanoma cells, weak CAM surface expression may provide a means for melanomas to escape immune surveillance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739916     DOI: 10.1002/cncr.2820690517

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Detachment of transformed cells. Role of CD44 variants.

Authors:  C Santos; K Chandler; S Zimmer; P B Fisher; U Gunthert; K W Anderson
Journal:  Cell Biophys       Date:  1995-02

2.  In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites.

Authors:  M Hishii; D Andrews; L A Boyle; J T Wong; F Pandolfi; P J van den Elsen; J T Kurnick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.

Authors:  M Hishii; J T Kurnick; T Ramirez-Montagut; F Pandolfi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation.

Authors:  Xiaoyue Chen; Richard Wong; Ildar Khalidov; Andrew Y Wang; Jeerapond Leelawattanachai; Yi Wang; Moonsoo M Jin
Journal:  Biomaterials       Date:  2011-07-23       Impact factor: 12.479

5.  Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes.

Authors:  D J Cole; J K Taubenberger; B A Pockaj; J R Yannelli; C Carter; J Carrasquillo; S Leitman; S M Steinberg; S A Rosenberg; Y C Yang
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

Review 6.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

7.  T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.

Authors:  F Pandolfi; L A Boyle; L Trentin; A Oliva; J T Kurnick
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

Authors:  A Grothey; P Heistermann; S Philippou; R Voigtmann
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

9.  The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.

Authors:  C L Alexander; M Edward; R M MacKie
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

Review 10.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.